Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page’s 403 error.
    Difference
    1%
    Check dated 2026-10-24T22:27:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T22:33:19.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:28.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden markup and the Home label from the page’s HTML, affecting only the error/navigation elements rather than the visible study content. The core study details remain unchanged.
    Difference
    0.5%
    Check dated 2026-09-26T22:06:35.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study record content. This indicates the resource is unavailable or access-restricted, preventing users from viewing the trial details.
    Difference
    20%
    Check dated 2026-09-19T21:51:33.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new page revision, v3.6.6, was added and the previous revision v3.6.5 was removed. This indicates a backend or formatting update to the page without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:44:37.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.